1. Missero C, Cobellis G, DeFelice, DiLauro R. Molecular events involved in differentiation of thyroid follicular cells. Mol Cell Endocrinol 1998, 140:37
2. Lazzaro F, Price M, De Felice M, Di Lauro R. The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. Development 1991;113:1093
3. Plachov D, Chowdhury K, Walther C, Simon D, Guenet JL, Gruss P. Pax8, a murine paired box gene expressed in the developing excretory system and thyroid gland. Development 1990;110:643
4. Zannini M, Avantaggiato V, Biffali E, et al. TTF-2, a new forkhead protein, shows a temporal expression in the developing thyroid which is consistent with a role in controlling the onset of differentiation. EMBO J. 1997;11:3185
5. Damante G, di Lauro R. Thyroid-specific gene expression. Biochim Biophys Acta 1994;1218:255
6. Kimura S. thyroid-specific enhancer-binding protein. Role in thyroid function and organogenesis. Trends Endocrinol Metab 1996;7:247
7. Kimura S, Hara Y, Pineau T, et al. The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev 1996;10:60
8. Mansouri A, Chowdhury K, Gruss P. Follicular cells of the thyroid gland require Pax8 gene function. Nature Genet 1998;19:87
9. Manley NR, Capecchi MR. The role of Hoxa-3 in mouse thymus and thyroid development. Development 1995;121:1989
10. Guazzi S, Lonigro R, Pintonello L, Boncinelli E, Di Lauro R, Mavilio F. The thyroid transcription factor-1 gene is a candidate target for regulation by Hox proteins. EMBO J 1994;13:3339
11. Rodriguez M, Santisteban P, Acebron A, Hernandez LC, Del Valle M, Jolin T. Expression of thyroglobulin gene in maternal and fetal thyroid in rats. Endocrinology 1992;131:415
12. De Felice M, Ovitt C, Biffali E, et al. A mouse model for hereditary thyroid dysgenesis and cleft palate. Nature Genet 1998;19:395
12a. Fagman H, Grande M, Edsbagge J, Semb H, Nilsson M. Expression of classical cadherins in thyroid development: maintenance of an epithelial phenotype throughout organogenesis. Endocrinology 2003; 144:3618
13. Brown RS, Shalhoub V, DeVito W, Joris I, Lian J, Stein G. Ontogeny of thyrotropin receptor gene expression in fetal rat thyroid glands. Endocrinology 2000;141:340
14. Remy L, Michel-Bechet M, Athouel-Haon AM et al. Critical study of endogenous peroxidase activity: its role in the morphofunctional setting of the thyroid follicle in the rat fetus. Acta Histochem 1979;67:159
15. Kawaoi A, Tsuneda M. Functional development and maturation of the rat thyroid gland in the foetal and newborn periods: an immunohistochemical study. Acta Endocrinol 1985;108:518
16. Stein SA, Shanklin DR, Krulich L, Roth MG, Chubb CM, Adams PM. Evaluation and characterization of the hyt/hyt hypothyroid mouse:11. Abnormalities of TSH and the thyroid gland. Neuroendocrinology 1987;49:509
17. Brown RS, Bellisario RL, Botero D et al. Incidence of transient congenital hypothyroidism due to maternal thyrotropin receptor-blocking antibodies in over one million babies. J Clin Endocrinol Metab 1996;81:1147
18. Abramowicz MJ, Duprez L, Parma J, Vassart G, Heinrichs C. Familial congenital hypothyroidism due to inactivating mutation of the thyrotropin receptor causing profound hypoplasia of the thyroid gland. J Clin Invest 1997;99:3018
19. Dussault JH, Labrie F. Development of the hypothalamic-pituitary-thyroid axis in the neonatal rat. Endocrinology 1975;97:1321
20. Fisher DA, Klein AH: Thyroid development and disorders of thyroid function in the
newborn. New England Journal of Medicine 1981;304:702
21. Burrow GN, Fisher DA, Larsen PR: Mechanisms of disease:maternal and fetal thyroid function. N Eng J Med 1994;331:1072
22. Bellabio M, Nicolini U, Jowett T, Ruiz de Elvira MC, et al: Maturation of thyroid function in normal human fetuses. Clin Endocrinol 1989;31:565
23. Contempre B, Jauniaux E, Calvo R: Detection of thyroid hormones in human embryonic cavities during the first trimester of pregnancy. J Clin Endocrinol Metab 1993;77:1719
24. Costa A, Arisio R, Benedetto C, Bertino E, et al: Thyroid hormones in tissues from human embryos and fetuses. J Endocrinol Invest 1991;14:550
25. Thorpe-Beeston JG, Nicolaides KH, McGregor AM: Fetal thyroid function. Thyroid 1992;2:207
26. Thorpe-Beeston JG, Nicolaides KH, Felton CV, Butler J, et al: Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus. N Eng J Med 1991;324:532
27. DeNayer PH, Cornette C, Vanderschueren M et al: Serum thyroglobulin levels in preterm neonates. Clin Endocrinol 1984;21:149
28. Roti E, Gnudi A, Braverman LE: The placental transport, synthesis and metabolism of hormones and drugs which affect thyroid function. Endocr Rev 1983;4:131
29. Klein AH, Hobel CJ, Sack J, Fisher DA: Effect of intraamniotic fluid thyroxine injection on fetal serum and amniotic fluid iodothyronine concentrations. J Clin Endocrinol Metab 1978;47:1034
30. Polk DA, Reviczky A, Lam RW et al: TRH in the ovine fetus: ontogeny and effect of thyroid hormone. Am J Physiol 1991;23: E53
31. Kester MH, Martinez de Mena R, Obregon MJ et al. Iodothyronine levels in the human developing brain: major regulatory roles of iodothyronine deiodinases in different areas. J Clin Endocrinol Metab 2004;89:3117
32. Bates JM, St Germain DL, Galton VA. Expression prolfiles of the three deiodinases, D1, D2, and D3, in the developing rat. Endocrinology 1999;140:844
33. Van der Geyten S, Segers I, Gereben B et al. Transcriptional regulation of iodothyronine deiodinases during embryonic development. Mol Cell Endocrinol 2001;183:1
33. Crantz FR, Silva JE, Larsen PR: Analysis of the sources and quantity of 3,5,3'-triiodothyronine specifically bound to nuclear receptors in rat cerebral cortex and cerebellum. Endocrinology 1982;110:367
34. Ruiz de Ona C, Morreale de Escobar G, Calvo R, Escobar del Rey R, et al: Thyroid hormone and 5'-deiodinase in the rat fetus late in gestation: effects of maternal hypothyroidism. Endocrinology 1991;128:422
35. Ferreiro B, Bernal J, Goodyer CG, Branchard CL: Estimation of nuclear thyroid hormone receptor saturation in human fetal brain and lung during early gestation. J Clin Endocrinol Metab 1988;67:853
36. Roti E, Fang SL, Green K, Emerson CH, et al: Human placenta is an active site of thyroxine and 3,3',5-triiodothyronine tyrosyl ring deiodination. J Clin Endocrinol Metab 1981;53:498
37. Fisher DA: Disorders of the thyroid in the newborn and infant. In: Sperling M (ed) Pediatric Endocrinology, WB Saunders Co., Philadelphia, 51, 1996
38. Chopra IJ, Wu SY, Chua Teco GN, Santini F: A radioimmunoassay for measurement of 3,5,3'-triiodothyronine sulfate; studies in thyroidal and non-thyroidal disease, pregnancy and neonatal life. J Clin Endocrinol Metab 1992;75:189
39. Sharifi J, St.Germain DL: The cDNA for the type I iodothyronine 5'-deiodinase encodes an enzyme manifesting both high Km and low Km activity. J Biol Chem 1992;267:12539
40. Wu SY, Huang WS, Polk D, Forsheim WH, et al: Identification of thyroxine sulfate (T4S) in human serum and amniotic fluid by a novel T4S radioimmunoassay. Thyroid 1992;2:101
41. Polk DH, Reviczky A, Wu SY, Huang WS, et al: Metabolism of sulfoconjugated thyroid hormone derivatives in developing sheep. Am J Physiol 1994;266:E892
42. Meinhold H, Dudenhausen JW, Wenzel KW, Saling E: Amniotic fluid concentrations of 3,3'3'-tri-iodthyronine (reverse T3), 3,3'-di-iodothyronine, 3,5,3'-tri-iodothyronine (T3) and thyroxine (T4) in normal and complicated pregnancy. Clin Endocrinol 1979;10:355
43. Santini F, Hurd RE, Chopra IJ: A study of metabolism of deaminated and sulfoconjugated iodothyronines by rat placental iodothyronine 5-monodeiodinase. Endocrinology 1992;131:1689
44. Kaplan MM, Yakoski KA: Maturational patterns of iodothyronine phenolic and tyrosyl ring deiodinase activities in rat cerebrum, cerebellum, and hypothalamus. J Clin Invest 1980;67:1204
45. Silva JE, Larsen PR: Comparison of iodothyronine 5'-deiodinase and other thyroid-hormone-dependent enzyme activities in the cerbral cortex and hypothyroid neonatal rat. J Clin Invest 1982;70:1110
46. Vulsma T, Gons MH, DeVijlder JMM: Maternal fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect of thyroid dysgenesis. N Eng J Med 1989;321:13
47.Chan SY, Franklyn, JA, Kilby MD. Maternal thyroid hormones and fetal brain development. Curr Opinion Endocrinol Diabetes 2005;12:23
48. Obregon MJ, Mallol J, Pastor RM, Morreale de Escobar G, et al: L-thyroxine and 3,5,3'-triiodothyronine in rat embryos before onset of fetal thyroid function. Endocrinology 1984;114:305
49. Morreale de Escobar G, Obregon MJ, Ruiz de Ona C, Escobar del Rey F: Transfer of thyroxine from the mother to the rat fetus near term: effects on brain 3,5,3'-triiodothyronine deficiency. Endocrinology 1988;122:1521
50. Calvo R, Obregon MJ, Escobar del Rey F, Morreale de Escobar G: The rat placenta and the transfer of thyroid hormones from the mother to the fetus: effects of maternal thyroid status. Endocrinology 1992;131:357
51. Morreale de Escobar G, Calvo R, Obregon MJ, Escobar del Rey F: Contribution of maternal thyroxine to fetal thyroxine pools in normal rats near term. Endocrinology 1990;126:2765
52. Fisher DA, Lehman H, Lackey C: Placental transport of thyroxine. J Clin Endocrinol 1964;24:393
53. Davidson KM, Richards DS, Schatz DA, Fisher DA: Successful in utero treatment of fetal goiter and hypothyroidism. N Eng J Med 1991; 324:543
54. Czernikow M, Schlumberger M, Pomarede R et al: Plasma thyroglobulin measurements help determine the type of thyroid defect in congenital hypothyroidism. J Clin Endocrinol Metab 1983;56:242
54a. Davidson KM, Richards DA, Schatz DA, Fisher DA: Successful in utero treatment of fetal goiter and hypothyroidism. N Engl J Med 1991; 234:543
55. Abuid J, Klein AH, Foley Jr,T.P., Larsen PR: Total and free triiodothyronine and thyroxine in early infancy. J Clin Endocrinol Metab 1974;39:263
56. Abuid J, Stinson DA, Larsen PR: Serum triiodothyronine and thyroxine in the neonate and the acute increases in these hormones following delivery. J Clin Invest 1973; 52:1195
57. Bianco AC, Kieffer JD, Silva JE: Adenosine 3',5'-monophosphate and thyroid hormone control of uncoupling protein messenger ribonucleic acid in freshly dispersed brown adipocytes. Endocrinology 1992;130:2625
58. Houstek J, Vizek K, Stanislav P, Kopecky J, et al: Type II iodothyronine 5' deiodinase and uncoupling protein in brown adipose tissue of human newborns. J Clin Endocrinol Metab 1993;77:382
58a. Hume R, Simpson J, Delahunt C et al. Human fetal and cord serum thyroid hormones: developmental trends and interrelationships. J Clin Endocrinol Metab 2004;89:4097
59. Mercado M, Yu VYH, Szymonowiczw et al: Thyroid function in very preterm infants. Early Human Dev 1988;1916:131
60. LaFranchi S: Thyroid function in the preterm infant. Thyroid 1999;9:71
61. Fisher DA: Thyroid physiology in the perinatal period and during childhood. In: Braverman LE, Utiger RD (eds). Werner's and Ingbar's The Thyroid, Lipincott-Raven, Philadelphia, 974, 1996
62. Ares S, Escobar-Morreale HF, Quero J et al: Neonatal hypothyroxinemia: effects of
iodine intake and premature birth. J Clin Endocrinol Metab 1997;82:1704
63. Frank JE, Faix JE, Hermos R et al: Thyroid function in very low birth weight infants: effects in neonatal hypothyroidism screening. J Pediatr 1996;128:548
64. Guillaume J, Schussler GC, Goldman J: Components of the total serum thyroid hormone concentrations during pregnancy: high free thyroxine and blunted thyrotropin (TSH) response to TSH-releasing hormone in the first trimester. J Clin Endocrinol Metab 1985;60:678
65. Pezzino V, Filetti S, Belfiore A, Proto S, et al: Serum thyroglobulin levels in the newborn. J Clin Endocrinol 1981;52:364
66. Thorpe-Beeston JG, Nicolaides KH, Snijders RJ, Felton CV, et al: Thyroid function in small for gestational age fetuses. Obstet Gynecol 1991;77:701
67. Fisher DA, Polk DH, Wu SY: Fetal thyroid metabolism: a pluralistic system. Thyroid 1994;4:367
68. Porterfield SP, Hendrich CE: The role of thyroid hormones in prenatal and neonatal neurological development—current perspectives. Endocr Rev 1993;14:94
69. Hebert R, Langlois JM, Dussault JH: Permanent defects in rat peripheral auditory function following perinatal hypothyroidism: determination of a critical period. Dev Brain Res 1985;23:161
70.Lavado-Autric R, Auso E, Garcia-Velasco JV et al. Early maternal hypothyroxinemia alters histogenesis and cerebral cortex cytoarchitecture of the progeny. J Clin Invest 2003;111:1073
71. Delange F: Neonatal screening for congenital hypothyroidism: results and perspectives. Horm Res 1997;48:51
72. Van Vliet G: Neonatal hypothyroidism: treatment and outcome. Thyroid 1999;9:79
73. Bongers-Shokking JJ, Koot HM, Wiersma D et al. Influence of timing and dose of thyroid hormone replacement on development in infants with congenital hypothyroidism. J Pediatr 2000;136:292
74. Salerno M, Militerni R, Bravaccio C et al. Effect of different starting doses of levothyroxine on growth and intellectual outcome at four years of age in congenital hypothyroidism. Thyroid 2002;12:45
75. Morreale de Escobar G, Obregon MJ, Escobar del Rey F. Clinical Perspective: Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia? J Clin Endocrinol Metab 2000;85:3975
76. Calvo RM, Jauniaux E, Gulbis B et al. Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of development. J Clin Endocrinol Metab 2002;87:1768
77. Halpern JP, Boyages SC, Maberly GF: The neurology of endemic cretinism. A study of two endemias. Brain 1991;114:825
78. Boyages SC, Halpern JP: Endemic cretinism: toward a unifying hypothesis. Thyroid 1993;3:59
73. Dunn JT: Iodine Supplementation and the Prevention of Cretinism. Annals New York Academy of Sciences 678:158, 1993
75. Larsen, P.R. Regulation of thyroid hormone metabolism. In: Delong GR, Robbins J, Condliffe, PG (eds). Iodine and the Brain, Plenum 5, 1989
76. Boyages SC: Clinical review 49: Iodine deficiency disorders. J Clin Endocrinol Metab 77:587, 1993
78. Ma T, Lian ZC, Qi SP, Heinz ER, et al: Magnetic resonance imaging of brian and the neuromotor disorder in endemic cretinism. Ann Neurol 34:91, 1993
79. Cao XY, Jiang XM, Dou ZH et al. Timing of vulnerability of the brain to iodine deficiency in endemic cretinism. N Engl J Med 1994;331:1739
80. Pharoah POD, Connolly KJ, Ekins RP, Harding AG: Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clin Endocrinol 1984;21:265
81. New England Congenital Hypothyroid Collaborative: correlation of cognitive test scores and adequacy of treatment in adolescents with congenital hypothyroidism. J Pediatr 1994;124:383
82. Glorieux J, Dussault J, Van Vliet G: Intellectual devlopment at age 12 years of children with congenital hypothyroidism diagnosed by neonatal screeening. J Pediatr 1992;121:581
83. New England Congenital Hypothyroidism Collaborative : Effects of neonatal screening for hypothyroidism; prevention of mental retardation by treatment before clinical manifestations. Lancet 1981;2:1095
83a. Rovet J, Walker W, Bliss B, Buchanan L, Ehrlich R: Long-term sequelae of hearing impairment in congenital hypothyroidism. J Pediatr 1996;128:776
83b. Bellman SC, Davies A, Fuggle PW, Grant DB, Smith I. Mild impairment of neuro-otological function in early treated congenital hypothyroidism. Arch Dis Childhood 1996;74: 215
84. DeZegher F, Pernasetti F, Vanhole C et al: The prenatal role of thyroid hormone evidenced by fetomaternal Pit-1 deficiency. J Clin Endocrinol Metab 1995;80:3127
85. Matsuura N, Konishi J, and the transient hypothyroidism study group in Japan: Endocrinol Japon 1990;37:369
86. Man EB, Brown JF, Serunian SA: Maternal hypothyroxinemia: psychoneurological deficits of progeny. Ann Clin Lab Ser 1991;21:227
86a. Haddow JE, Palomaki GE, Allan WC, Williams JR et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999;341:549
86b. Pop VJ, Kuljpens JL, van Baar AL, Verkerk G et al. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol 1991;50:149
86c. Klein RZ, Haddow JE, Faix JD, Brown RS, Hermos R, Pulkkinen A, Mitchell ML. Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol 1991;35: 41
86d. Pop V, van Baar AL, Vulsma T. should all pregnant women be screened for hypothyroidism? Lancet 1999;354:1224
86e. Brown RS, LaFranchi SH, The American Thyroid Association Public Health Committee Statement. Haddow Study of Maternal Hypothyroidism during pregnancy and subsequent childhood neuropsychological development. Thyroid 1999;9: 971
87. Liu H, Momotani N, Noh JY, Ishikawa N, et al: Maternal hypothyroidism during early pregnancy and intellectural development of progeny. Arch Intern Med 1994;154:785
88. Brent GA: The molecular basis of thyroid hormone action. N Engl J Med 1994;331:847
89. Bernal J, Pekonen F: Ontogenesis of the nuclear 3,5,3'-triiodothyronine receptor in the human fetal brain. Endocrinology 1984;114:677
90. Rodd C, Schwartz HL, Strait KA, Oppenheimer JH: Ontogeny of hepatic nuclear triiodothyronine receptor isoforms in the rat. Endocrinology 1992;131:2559
91. Strait KA, Schwartz HL, Perez-Castillo A, Oppenheimer JH: Relationship of c-erbA mRNA content in tissue triiodothyronine nuclear binding capacity and function in developing and adult rats. J Biol Chem 1990;265:10514
92. Bradley DJ, Towle HC, Young III WS: Spatial and temporal expression of a- and b-thyroid hormone receptors mRNAs, including the b2-subtype, in the developing mammalian central nervous system. J Neurosci 1992;12:2288
93. Bradley DJ, Towle HC, Young WS,III: a and b thyroid hormone receptor (TR) gene expression during auditory neurogenesis: Evidence for TR isoform-specific transcriptional regulation in vivo. Proc Natl Acad Sci USA 1994;91:439
94. Mellstrom B, Naranjo JR, Santos A, Gonzalez AM, et al: Independent expression of the alpha and beta c-erbA genes in developing rat brain. Mol Endocrinol 1991;5:1339, 1991
95. Yaoita Y, Brown DD: Correlation of thyroid hormone receptor gene expression with amphibian metamorphosis. Genes Dev 1990;4:1917
96. Forrest D, Hallbook F, Persson H, Vennstrom B: Distinct functions for thyroid hormone receptors a and b in brain development indicated by differential expression of receptor genes. EMBO 1991;10:269
97. Sjösberg M, Vennström B, Forrest D: Thyroid hormone receptors in chick retinal development: differential expression of mRNAs for a and N-terminal variant b receptors. Development 1992;114:39
98. Cook CB, Kakucska I, Lechan RM, Koenig RJ: Expression of thyroid hormone receptor b2 in rat hypothalamus. Endocrinology 1992;130:1077
99. Van Middlesworth L, Norris CH: Audiogenic seizures and cochlear damage in rats after perinatal antithyroid treatment. Endocrinology 1980;106:1686
100. Baker BS, Tata JR: Accumulation of proto-oncogene c-erbA related transcripts during Xenopus development: association with early acquisition of response to thyroid hormone and estrogen. EMBO J 1990;9:879
101. Yaoita Y, Shi YB, Brown DD: Xenopus laevis a and b thyroid hormone receptors. Proc Natl Acad Sci USA 1990;87:7090
102. Banker DE, Bigler J, Eisenman RN: The thyroid hormone receptor gene (c-erbAa) is expressed in advance of thyroid gland maturation during the early embryonic development of Xenopus laevis. Mol Cell Biol 1991;11:5079
103. Leonard JL, Larsen PR: Thyroid hormone metabolism in primary cultures of fetal rat brain cells. Brain Res 1985;327:1
104. Kolodny JM, Leonard JL, Larsen PR, Silva JE: Studies of nuclear 3,5,3'-triiodothyronine binding in primary cultures of rat brain. Endocrinology 1985;117:1848
105. Leonard JL, Farwell AP, Yen PM, Chin WW, et al: Differential Expression of thyroid hormone receptor isoforms in neurons and astroglial cells. Endocrinology 1994;135:548
106. Castiglia D, Cestelli A, Di Liegro C, Bonfanti L, et al: Accumulation of Different c-ErbA Transcripts During Rat Brain Development and in Cortical Neurons Cultured in a Synthetic Medium. Cell Mol Neurobiol 1992;12:259
107. Strait KA, Zou L, Oppenheimer JH: b1 isoform-specific regulation of a triiodothyronine-induced gene during cerebellar development. Mol Endocrinol 1992;6:1874
108. Morte B, Manzano J, Scanlan T, Vennstrom B, Bernal J. Deletion of the thyroid hormone receptor 1 prevents the structural alterations of the cerebellum induced by hypothyroidism. Proc Natl Acad Sci USA 2002;99:3985
109. Anderson GW, Schoonover CM, Jones SH. Control of thyroid hormone action in the developing rat brain. Thyroid 2003;13:1039
110. Legrand J: Variations as a function of age, of the response of the cerebellum to morphogenetic action of the thyroid in rats. Microscopy Morphol Exp 1967;56:291
111. Bernal J. Action of thyroid hormone in brain. J Endocrinol Invest 2002;25:268
112. Bernal J, Guadano-Ferraz M, Morte B. Perspectives in the study of thyroid hormone action in brain development and function. Thyroid 2003;13:1005
113. Hauser P, Zametkin AJ, Martinez P et al: Attention deficit-hyperactivity disorder in people with generalized resistance to thyroid hormone. N Engl J Med 1993;328:997
114. Refetoff S, DeWind LT, DeGroot LJ: Familial syndrome combining deaf-mutism, stipplled epiphyses, goiter, and abnormally high PBI:possible target organ refractoriness to thyroid hormone. J Clin Endocrinol Metab 1967;27:279
115. Foley TP, Jr: Congenital hypothyroidism. In: Braverman LE, Utiger RD (eds). Werner's and Ingbar's The Thyroid, Lipincott-Raven, Philadelphia, 988, 1996
116. Dussault JH: Screening for congenital hypothyroidism. Clin Obstetr Gynecol 1997;40:117
117. Klein AH, Meltzer S, Kenney FN: Improved prognosis in congenital hypothyroidism treated before age 3 months. J Pediatr 1972;81:912
118. Dussault JH, Laberge C: A new method for detection of hypothyroidism in the newborn. Clin Res 1972;20:,918
119. Mitchell ML, Larsen PE, Levy HL, Bennett AJE, Madoff MA. Screening for congenital hypothyroidism. J. A. M.A. 1978;239:2348
120. Dussault JH. The anecdotal history of screening for congenital hypothyroidism. J Clin Endocrinol Metab 1999;84:4332
121. Lafranchi S, Dussault JH, Fisher DA, et al: American Academy of Pediatrics and American Thyroid Association. Newborn screening for congenital hypothyroidism: recommended guidelines. Pediatrics 1993;91:1203
122. Klein RZ, Mitchell ML: Hypothyroidism in infants and children In: Braverman LH, Utiger RD (eds). Werner's and Ingbar's The Thyroid, Lipincott-Raven, Philadelphia, 984, 1996
123. Dussault JH, Morisette J. Higher sensitivity of primary thyrotropin in screening for congenital hypothyroidism: a myth? J Clin Endocrinol Metab 1983;56:849
124.LaFranchi SH, Hanna CE, Krainz PL et al: Screening for congenital hypothyroidism with specimen collection at two time periods: results of the northwest regional screening program. Pediatrics 1985;76:734
125. Hunter MK, Mandel SH, Sesser DE et al. Follow-up of newborns with low thyroxine and nonelevated thyroid-stimulating hormone-screening concentrations: results of the 20-year experience in the Northwest Regional Newborn Screening Program. J Pediatr 1998;132:70
126.Larson C, Hermos R, Delaney A, Daley D, Mitchell M. Risk factors associated with delayed thyrotropin elevations in congenital hypothyroidism. J Pediatr 2003;143:587
126a. Perry R, Heinrichs C, Bourdoux P, Khoury K, Szots F, Dussault JH, et al. Discordance of monozygotic twins for thyroid dysgenesis: implications for screening and for molecular pathophysiology. J Clin Endocrinol Metab 2002;87:4072
127. Fisher DA: Effectiveness of newborn screening programs for congenital hypothyroidism: prevalence of missed cases. Ped Clin N Am 1987;34:881
128. Adams LM, Emery JR, Clark SJ et al: Reference ranges for newer thyroid function tests in premature infants. J Pediatr 1995;126:122
129. Brown RS: Thyroid disease in infancy, childhood, and adolescence. In: Braverman LE (ed). Contemporary Endocrinology, Humana Press, Totowa , 81, 1997
130. Fort P, Lifshitz F, Bellisario R, et al: Abnormalities of thyroid function in infants with Down syndrome. J Pediatr 1984;104:545
131. DeVriendt K, VanHole C, Matthijs G et al: Deletion of thyroid transcription factor-1 gene in an infant with neonatal thyroid dysfunction and respiratory failure. N Engl J Med 1998;338:1317
132.Perna MG, Civitareale D, De Filippis V et al: Absence of mutations in the gene encoding thyroid transcription factor-1 (TTF-1) in patients with thyroid dysgenesis. Thyroid 1997;7:377
133. Lapi P, Macchia PE, Chiovato L et al: Mutations in the gene encoding thyroid transcription factor-1 (TTF-1) are not a frequent cause of congenital hypothyroidism (CH) with thyroid dysgenesis. Thyroid 1997;7:383
134. Macchia PE, Lapi P, Krude H et al: Pax8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis. Nature Genet 1998;19:83
135. Clifton-Blighe RJ, Wentworth JM, Heinz P et al: Mutation of the gene encoding human TTF-2 associated with thyroid agenesis, cleft palate and choanal atresia. Nature Genet 1998;19: 399
136. Abramowicz MJ, Vassart G, Refetoff S: Probing the cause of thyroid dysgenesis. Thyroid 1997;7: 325
136a. Brown RS, Demmer LA. Editorial: The etiology of thyroid dysgenesis-still an enigma after all these years. J Clin Endocrinol Metab 2002;87:4069
137. Dussault JH, Letarte J, Guida H et al: Lack of influence of thyroid antibodies on thyroid function in the newborn infant and on a mass screening program for congenital hypothyroidism. J. Pediatr 1980;96:385
138. Van der Gaag RD, Drexhage HA, Dussault JH: Role of maternal immunoglobulins blocking TSH-induced thyroid growth in sporadic forms of congenital hypothyroidism. Lancet 1985;1:246
139. Bogner U, Gruters A, Sigle B et al: Cytotoxic antibodies in congenital hypothyroidism. J Clin Endocrinol Metab 1989;68:671
140. Brown RS, Keating P, Mitchell E: Maternal thyroid-blocking immunoglobulins in congenital hypothyroidism. J Clin Endocrinol Metab 1990;70:1341
141. Medeiros-Neto G: Clinical and molecular advances in inherited disorders of the thyroid system. Thyroid Today 1996;19:1
142. de Vijlder JJM, Ris-Stalpers C, Vulsma T: Inborn errors of thyroid hormone biosynthesis. Exp Clin Endocrinol Diabetes (Suppl) 1997;105:32
143. Kopp P: Pendred's syndrome: identification of the genetic defect a century after its recognition. Thyroid 1999;9:65
143a. Royaux IE, Suzuki K, Mori A et al. Pendrin, the protein encoded by the Pendred syndrome gene (PDS) is an apical porter of iodide in the thyroid and is regulated by thyroglobulin FRTL-5 cells. Endocrinology 2000;141:839
143b. Moreno JC, Bikker H, Kempers MJ et al. Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism. N Engl J Med 2002;347:95
144. Sunthornthepvarakul T, Gottschalk ME, Hayashi Y et al: Brief report: resistance to thyrotropin caused by mutations in the thyrotropin-receptor gene. N Engl J Med 1995;332:155
145. Clifton-Bligh RJ, Gregory JW, Ludgate GM et al: Two novel mutationos in the thyrotropin (TSH) receptor gene in a child with resistance to TSH. J Clin Endocrinol Metab 1997;82:1094
146. Biebermann H, Schoneberg T, Krude H et al: Mutations of the human thyrotropin receptor gene causing thyroid hypoplasia and persistant congenital hypothyroidism. J Clin Endocrinol Metab 1997;82:3471
147. Gagne N, Parma J, Deal C et al: Apparent congenital athyreosis contrasting with normal plasma thyroglobulin levels and associated with inactivating mutations in the thyrotropin receptor gene: are athyreosis and ectopic thyroid distinct entities? J Clin Endocrinol Metab 1998;83:1771
148. Stein SA, Oates EL, Hall CR, et al: Identification of a point mutation in the thyrotropin receptor of the hyt/hyt hypothyroid mouse. Mol Endocrinol 1994;8:129
149. 149. Krude H, Biebermann H, Gopel et al: The gene for the thyrotropin receptor (TSHR) as a candidate gene for congenital hypothyroidism with thyroid dysgenesis. Exp Clin Endocrinol Diabetes 1996;104 (Suppl):117
150. Ahlbom BE, Yaqoob M, Larsson et al: Genetic and linkage analysis of familial congenital hypothyroidism: exclusion of linkage to the TSH receptor gene. Hum Genet 1997;99:186
151. Levine MA, Jap T-S, Hung W: Infantile hypothyroidism in two sibs: an unusual presentation of pseudohypoparathyroidism type 1a. J Pediatr 1985;107:919
152. Collu R, Tang J, Castagne J et al: A novel mechanism for isolated central hypothyroidism: inactivating mutations in the thyrotropin-releasing hormone receptor gene. J Clin Endocrinol Metab 1997;82:1361
153. Brown RS, Bhatia V, Hayes E: An apparent cluster of congenital hypopituitarism in central Massachusetts: magnetic resonance imaging and hormonal studies. J Clin Endocrinol Metab 1991;72:12
154. Dattani MT, Martinez-Barbera JP, Thomas PQ, et al: HESX1: a novel homeobox gene implicated in septo-optic dysplasia. Horm Res 1998;50(Suppl):8
155. Parks JS, Brown MR, Abdul-Latif H, et al: Abnormalities of the pituitary-specific transcription factor-1 gene and development. Clin Pediatr Endocrinol 1995;4:33
156. Rosenbloom AL, Almonte AS, Brown MR et al: Clinical and biochemical phenotype of familial anterior hypopituitarism from mutation of the PROP1 gene. J Clin Endocrinol Metab 1999;84:50
156a. Dumitrescu AM, Liao XH, Best TB, Brockmann K, Refetoff S. A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am J Hum Genet 2004;74:168.
157. Weiss RE, Balzano S, Scherberg NH et al.: Neonatal detection of generalized resistance to thyroid hormone. JAMA 1990;264:2245
158. McDermott MT, Ridgway EC: Thyroid hormone resistance syndromes. Am J Med 1993;94:424
159. Delange F: Iodine nutrition and congenital hypothyroidism In: Delange F, Fisher DA, Glinoer D (eds). Research in congenital hypothyroidism, Plenum Press, New York, 173,1989
160. Fisher DA: Editorial: The hypothyroxinemia of prematurity. J Clin Endocrinol Metab 1997;82:1701
161. Brown RS, Bloomfield S, Bednarek FJ et al: Routine skin cleansing with povidone-iodine is not a common cause of transient neonatal hypothyroidism in North America: a prospective, controlled study. Thyroid 1997;7:395
162. Chabrolle JP, Rossier A: Goiter and hypothyroidism in the newborn after cutaneous absorption of iodine. Arch Dis Child 1978;53:495
163. l'Allemand D, Gruters A, Beyer P et al: Iodine in contrast agents and skin disinfectants is the major cause for hypothyroidism in premature infants during intensive care. Horm Res 1987;28:42
164. Cheron RG, Kaplan MM, Larsen PR et al: Neonatal thyroid function after propylthiouracil therapy for maternal Graves' disease. N Engl J Med 1981;304:525
165. Brown RS, Bellisario RL, Botero D, et al: Incidence of transient congenital hypothyroidism due to maternal thyrotropin receptor-blocking antibodies in over one million babies. J Clin Endocrinol Metab 1996;81:1147
166. Pacaud D, Huot C, Gattereau A, et al: Outcome in three siblings with antibody-mediated transient congenital hypothyroidism. J Pediatr 1995;127:275
167. Mandel SH, Hanna CE, LaFranchi SH: Diminished thyroid-stimulating hormone secretion associated with neonatal thyrotoxicosis. J Pediatr 1986;109:662
168. Matsuura N, Harada S, Ohyama Y, et al: The mechanisms of transient hypothyroxinemia in infants born to mothers with Graves' disease. Pediatr Res 1997;42:214
168a. Daliva AL, Linder B, DiMartino-Nardi J, Saenger P. Three-year follow-up of borderline congenital hypothyroidism. J Pediatr 2000;136:53
168b. Calaciura F, Motta RM, Miscio G et al. Subclinical hypothyroidism in early childhood: a frequent outcome of transient neonatal hyperthyrotropinemia. J Clin Endocrinol Metab 2002;87:3209
169. Czernichow P, Vandalem JL, Hennen G: Transient neonatal hyperthyrotropinemia: a factitious syndrome due to the presence of heterophilic antibodies in the plasma of infants and their mothers. J Clin Endocrinol Metab 1981;53:387
170. Miki K, Nose O, Miyai K, et al. Transient infantile hyperthyrotropinemia. Arch Dis Child 1989;64:177
171. Fisher DA: Clinical Review 19: Management of congenital hypothyroidism. J Clin Endocrinol Metab 1991;72:523
171a. Ohnishi H, Sato H, Noda H, Inomata H, Sasaki N. Color Doppler ultrasonography: diagnosis of ectopic thyroid gland in patients with congenital hypothyroidism caused by thyroid dysgenesis. J Clin Endocrinol Metab 2003;88:5145
171b. Mehta A, Hindmarsh PC, Stanhope RG, Brain CE, Preece MA, Dattani MT. Is the thyrotropin-releasing hormone test necessary in the diagnosis of central hypothyroidism in children. J Clin Endocrinol Metab 2003;88:5696
172. Mitchell ML, Potischman N, Larsen PR, et al: Screening very-low-birthweight infants for congenital hypothyroidism. Lancet 1994;343:60
173. Reuss ML, Paneth N, Pinto-Martin JA, et al: The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. N Engl J Med 1996;334:821
174. van Wassenaer AG, Kok JH, de Vijlder JJM, et al: Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation. N Engl J Med 336:21,1997
174a. Briet JM, van Wassanaer AG, Dekker FW, de Vijlder JJM, van Baar A, Kok JH. Neonatal thyroxine supplementation in very preterm children: developmental outcome evaluated at early school age. Pediatrics 2001;107:712
174b.Rovet JF. In search of the optimal therapy for congenital hypothyroidism. J Pediatr 2004;144:698
174c. Simoneau-Roy J, Marti S, Deal C, Huot C et al. Cognition and behavior at school entry in children with congenital hypothyroidism treated early with high dose levothyroxine. J Pediatr 2004;144:747
174d. Bongers-Shokking JJ, Koot M, Wiersma D et al. Influence of timing and dose of thyroid hormone replacement on development in infants with congenital hypothyroidism. J Pediatr 2000;136:292
174e. Rovet JF, Ehrlich R. Psychoeducational outcome in children with early-treated congenital hypothyroidism. Pediatrics 2000;105: 515
174f. Cassio A, Cacciari E, Cicognani A,et al. Treatment for congenital hypothyroidism: thyroxine alone or thyroxine plus triiodothyronine? Pediatrics 2003;111:1055
175. Zakarija M, McKenzie JM: Pregnancy-associated changes in the thyroid-stimulating antibody of Graves' disease and the relationship to neonatal hyperthyroidism. J Clin Endocrinol Metab 1983; 57:1036
176. Skuza KA, Sills IN, Stene M, et al: Prediction of neonatal hyperthyroidism in infants born to mothers with Graves' disease. J Pediatr 1996;128:264
177. Fort P, Lifshitz F, Pugliese M, et al: Neonatal thyroid disease: differential expression in three sucessive offspring. J Clin Endocrinol Metab 1988;66:645
178. Zakarija M, McKenzie JM: Immunoglobulin G inhibitor of thyroid-stimulating antibody is a cause of delay in the onset of neonatal Graves' disease. J Clin Invest 1983;72:1352
179. Kohn LD, Suzuk K, Hoffman WH, et al: Characterization of monoclonal thyroid-stimulating and thyrotropin binding-inhibiting autoantibodies from a Hashimoto's patient whose children had intrauterine and neonatal thyroid disease. J Clin Endocrinol Metab 1997;82:3998
180. Neal PR, Jansen RD, Lemons JA, et al: Unusual manifestations of neonatal hyperthyroidism. Am J Perinatol 1985;2:231
181. Daneman D, Howard NH: Neonatal thyrotoxicosis: intellectual impairment and craniosynostosis in later years. J Pediatr 1980;97:257
182. Fisher DA: Neonatal thyroid disease in the offspring of women with autoimmune thyroid disease. Thyroid Today 1986;9(4):1
183. Matsuura N, Konishi J, Fujeda K, et al: TSH-receptor antibodies in mothers with Graves' disease and outcome in their offspring. Lancet 1988;2:14
184. Tamaki H, Amino N, Aozasa M, et al: Universal predictive criterai for neonatal overt thyrotoxicosis requiring treatment. Am J Perinatol 1988;5:152
185. Karpman BA, Rapoport B, Filetti S, et al: Treatment of neonatal hyperthyroidism due to Graves' disease with sodium ipodate. J Clin Endocrinol Metab 1987;64:119
186. Kopp P, Jameson JL, Roe TF: Congenital nonautoimmune hyperthyroidism in a nonidentical twin caused by a sporadic germline mutation in the thyrotropin receptor gene. Thyroid 1997;7:765
187. de Roux N, Polak M, Couet J, et al: A neomutation of the thyroid-stimulating hormone receptor in a severe neonatal hyperthyroidism. J Clin Endocrinol Metab 1996;81:2023
188. Schwab KO, Gerlich M, Broecker M, et al: Constitutively active germline mutation of the thyrotropin receptor gene as a cause of congenital hyperthyroidism. J Pediatr 1997;131:899
189. Holzapfel H-P, Wonerow P, von Petrykowski W, et al: Sporadic congenital hyperthyroidism due to a spontaneous germline mutation in the thyrotropin receptor gene. J Clin Endocrinol Metab 1997;82:3879
190. Gruters A, Schoneberg T, Biebermann, et al: Severe congenital hyperthyroidism caused by a germ-line neo mutation in the extracellular portion of the thyrotropin receptor. J Clin Endocrinol Metab 1998;83:1431
191. Foley TP, Abbassi V, Copeland KC, Draznin MB: Brief report: Hypothyroidism caused by chronic autoimmune thyroiditis in very young infants. N Engl J Med. 1994;330:466
192. Gilani BB, MacGillivray MH, Voorhees ML, et al: Thyroid hormone abnormalities in diagnosis of insulin-dependent diabetes mellitus in children. J Pediatr.1984;105:218
193. Neufeld M, MacLaren N, Blizzard R: Autoimmune polyglandular syndromes. Pediatr Ann.1980;9:154
194. Betterle C, Greggio NA, Volpato M: Clinical review 93: Autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab 1998;83:1049
195. Scott HS, Heino M, Peterson P, et al: Common mutations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients of different originis. Mol Endocrinol 1998;12:1112
196. LaFranchi S: Thyroiditis and acquired hypothyroidism. Pediatr Ann 1992;21:29
197. Leznoff A, Josse RG, Denburg J et al: Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol.1983;119:636
198. O'Regan S, Fong JSC, Kaplan BS, et al: Thyroid antigen-antibody nephritis. Clin Immunol Immunopathol.1976;6:341
199. Matsuura N, Konishi J, Yuri K, et al: Comparison of atrophic and goitrous auto-immune thyroiditis in children: clinical, laboratory and TSH-receptor antibody studies. Eur J Pediatr.1990;149:529
200. Takasu N, Yamada T, Takasu K, et al: Disappearance of thyrotropin-blocking antibodies and spontaneous recovery from hypothyroidism in autoimmune thyroiditis. New Engl J Med.1992;326:513
201. Brown RS: Immunoglobulins affecting thyroid growth: A continuing controversy. J Clin Endocrinol Metab.1995;80:1506
202. Rallison ML, Dobyns BM, Keating FR, et al: Occurrence and natural history of chronic lymphocytic thyroiditis in childhood. J Pediatr.1975;86:675
203. Maenpaa J, Raatikka M, Rasanen J, et al: Natural course of juvenile autoimmune thyroiditis. J Pediatr.1985;107:898
204. Moore DC: Natural course of "subclinical" hypothyroidism in childhood and adolescence. Arch Pediatr Adolesc Med 1996;150:293
205. Surks MI, Sievert R. Drugs and thyroid function. N Engl J Med.1995;333: 1688
205a. McCowen KC, Garber JR, Spark R. Elevated serum thyrotropin in thyroxine-treated patients with hypothyroidism given sertraline. N Engl J Med 1997;337: 1010
206. Barsano CP: Other forms of primary hypothyroidism. In: Braverman LE, Utiger RD (eds). Werner and Ingbar's The Thyroid, Lipincott-Raven, 956, 1996
207. Pacaud D, Van Vliet G, Delvin E, et al: A third world endocrine disease in a 6-year old North American boy. J Clin Endocrinol Metab 80:2574,1995
207a. Huang SA, Tu HM, Harney JW, Venihaki M, Butte AJ, Kozakewich HP, et al. Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med 2000;343(3):185-9.
208. Najjar SS: Muscular hypertrophy in hypothyroid children: the Kocher-Debre-Semelaigne syndrome. J Pediatr 1974;85:236
209. Van Wyk J, Grumbach M: Syndrome of precocious menstruation and galactorrhea in juvenile hypothyroidism: an example of hormonal overlap in pituitary feedback. J Pediatr 1960;57:416
210. Hopwood NJ, Lockhart LH, Bryan GT: Acquired hypothyroidism with muscular hypertrophy and precocious testicular enlargement. J Pediatr 1974;85:233
211. Anasti JN, Flack MR, Froehlich J, et al: A potential novel mechanism for precocious puberty in juvenile hypothyroidism. J Clin Endocrinol Metab 1995;80:276
212. Alos N, Huot C, Lambert R, et al: Thyroid scintigraphy in children and adolescents with Hashimoto disease. J Pediatr.1995;127:951
213. Rovet JF, Daneman D, Bailey JD: Psychologic and psychoeducational consequences of thyroxine therapy for juvenile acquired hypothyroidism. J Pediatr.1993;22:543
214. Van Dop C, Conte FA, Koch TK, et al: 1983 Pseudotumor cerebri associated with initiation of levothyroxine therapy for juvenile hypothyroidism. N Engl J Med 1983;308:1076
214a. Surks MI, Ortiz E, Daniels GH et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004;291;228
215. Rivkees SA, Bode HH, Crawford JD: Long-term growth in juvenile acquired hypothyroidism: the failure to achieve normal adult stature. N Engl J Med 1988;318:599
216. van der Gaag RD, Drexhage HA, Wiersinga WM, et al: Further studies in thyroid growth-immunoglobulins in euthyroid non-endemic goiter. J Clin Endocrinol Metab.1985;60:972
217. Rother KI, Zimmerman D, Schwenk WF: Effect of thyroid hormone treatment on thyromegaly in children and adolescents with Hashimoto disease. J Clin Endocrinol Metab.1994;124:599
218. Brown RS: Thyroiditis In: Rakel (ed). Conn's Current Therapy, WB Saunders Co, Philadelphia, 535,1987
219. Foley TP: Thyrotoxicosis in childhood. Pediatr Ann.1992;21:43
220. Shulman DI, Muhar I, Jorgensen EV, et al: Autoimmune hyperthyroidism in prepubertal children and adolescents: comparison of clinical and biochemical features at diagnosis and responses to medical therapy. Thyroid 1997;7:755
221. Tahara K, Ban T, Minegishi T, et al: Immunoglobulin from Graves' disease patients interact with different sites on TSH receptor/LH-CG chimeras than either TSH or immunoglobulins from idiopathic myxoedema. Biochem Biophys Res Commun.1991;179:70
221a. Knight J, Laing P, Knight A et al. Thyroid-stimulating autoantibodies usually contain only lambda-light chains: evidence for “forbidden clone” theory. J Clin Endocrinol Metab 1986;62:342
221b. Williams RC Jr, Marshall NJ, Kilpatrick K et al. Kappa/lambda immunoglobulin distribution in Graves’ thyroid-stimulating antibodies. Simultaneous analysis of C lambda gene polymorphisms. J Clin Invest 1988;82:1306
222. Bellur S, Tahara K, Saji M, et al: Repeatedly passed FRTL-5 rat thyroid cells can develop insulin and insulin-like growth factor-1-sensitive cyclooxygenase and prostaglandin E2 isomerase-like activities together with altered basal and thyrotropin-responsive thymidine incorporation into DNA. J Clin Endocrinol Metab.127:1526,1990
223. Southgate K, Creagh FM, Teece M, Kingswood C, Rees Smith B. A receptor assay for the measurement of TSH receptor antibodies in unextracted serum. Clin Endocrinol 1984;20:539
223a. Costagliola S, Morgenthaler NG, Hoermann R et al. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves’ disease. J Clin Endocrinol Metab 1999;84: 90
223b. Bolton J, Sanders J, Oda Y et al. Measurement of thyroid-stimulating hormone receptor autoantibodies by ELISA. Clin Chem 1999;45:2285
223c. Rees Smith B, Bolton J, Young S et al. A new assay for thyrotropin receptor autoantibodies. Thyroid 2004;14:830
223d. Evans C, Morgenthaler NG, Lee S, Llewellyn DH et al. Development of a luminescent bioassay for thyroid stimulating antibodies. J Clin Endocrinol Metab 1999;84:374
223e. Botero D, Brown RS: Bioassay of thyrotropin receptor antibodies with Chinese hamster ovary cells transfected with recombinant human thyrotropin receptor: clinical utility in children and adolescents with Graves' disease. J Pediatr 1998;132:612
224. Rivkees SA, Sklar C, Freemark M: Clinical Review 99: The management of Graves' disease in children, with special emphasis on radioiodine treatment. J Clin Endocrinol Metab 1998;83:3767
225. Collen RJ, Landaw EM, Kaplan SA, et al: Remission rates of children and adolescents with thyrotoxicosis treated with antithyroid drugs. Pediatrics.1980;65:550
226. Glaser NS, Styne DM: Predictors of early remission of hyperthyroidism in children. J Clin Endocrinol Metab 1997;82:1719
227. Hashizume K, Ichikawa K, Sakurai A, et al: Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. N Engl J Med.1991;324:947
228. McIver B, Rae P, Beckett G, et al: Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug. N Engl J Med.1996;334:220
229. Tajiri J, Joguchi S, Murakami T, et al: Antithyroid drug-induced agranulocytosis: the usefulness of routine white blood cell count monitoring. Arch Intern Med 1990;150:621
230. Levy WJ, Schumacher OP, Gupta M: Treatment of childhood Graves' disease. Cleve Clin J Med.1988;55:373
231. Nikiforov Y, Gnepp DR, Fagin JA. Thyroid lesions in children and adolescents after the Chernobyl disaster: implications for the study of radiation tumorigenesis. J Clin Endocrinol Metab 1996;81: 9
232. Hung W, Anderson KD, Chandra RS, et al: Solitary thyroid nodules in 71 children and adolescents. J Pediatr Surg.1992;27:1407
233. Schlumberger M, de Vathaire F, Travagli JP, Vassal G et al. Differentiated thyroid carcinoma in childhood: long term follow-up of 72 patients. J Clin Endocrinal Metab 1987;65: 1088
234. Flannery TK, Kirkland JL, Copeland KC, Bertuch AA, Karaviti LP, Brandt ML. Papillary thyroid cancer: A pediatric perspective. Pediatrics 1995;98: 464
235. Lairmore TC, Frisella MM, Wells SA Jr. Genetic testing and early thyroidectomy for inherited medullary thyroid carcinoma . Ann Med 1996;28: 401
236. Sarne DH, Schneider AB. External radiation and thyroid neoplasia. Endocrinol Metab Clin North Am 1996;25: 181
237. Soberman N, Leonidas JC, Cheriick I, Schiff R, Karayalcin. Sonographic abnormalities of the thyroid gland in longterm survivors of Hodgkin disease. Pediatr Radiol 1991;21: 250
238. Healy JC, Shafford EA, Reznek RH et al. Sonographic abnormalities of the thyroid gland following radiotherapy in survivors of childhood Hodgkin’s disease. Brit J Radiol 1996;69: 617
239. Gharib H, Zimmerman D, Goellner JR, Bridley SM, LeBlanc SM. Fine-needle aspiration biopsy: use in diagnosis and management of pediatric thyroid diseases. Endocr Pract 1995;1: 9
240. DeGroot LJ. Diagnostic approach and management of patients exposed to irradiation to the thyroid. J Clin Endocrinol Metab 1989;69:925
241. Zimmerman D, Hay ID, Gough IR Goellner JR et al. Papillary thyroid carcinoma in children and adults: Long-term follow-up of 1039 patients conservatively treated at one institution during three decades. Surgery 1988;104: 1157
242. Ladenson PW, Braverman LE, Mazzaferri EL et al. Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. N Engl J Med 1997;337: 888
243. Wohllk N, Cote GJ, Evans DB, Goepfert H, Ordonez NG, Gagel RF. Application of genetic screening information to the management of medullary thyroid carcinoma and multiple endocrine neoplasia type 2 (Review). Endocrinol Metab Clin N Am 1996;25: 1
244. Fogelfeld L, Wiviott L, Shore-Freeman E et al. Recurrence of thyroid nodules after surgical removal in patients irradiated in childhood for benign conditions. N Engl J Med 1989;320: 835